In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum

BACKGROUND: Schistosomiasis is a debilitating neglected tropical disease that affects approximately 190 million people around the world. Praziquantel (PZQ) is the only drug available for use against all Schistosoma species. Although PZQ has a high efficacy, recognized concerns have prompted the deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoli, Yu, Dan, Li, Chunxiang, Zhan, Tingzheng, Zhang, Tingting, Ma, Huihui, Xu, Jing, Xia, Chaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500042/
https://www.ncbi.nlm.nih.gov/pubmed/31053083
http://dx.doi.org/10.1186/s13071-019-3442-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500042/
https://www.ncbi.nlm.nih.gov/pubmed/31053083
http://dx.doi.org/10.1186/s13071-019-3442-7

Ejemplares similares